RN7SL201P

Across TCGA pan-cancer cohorts, RN7SL201P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RN7SL201P data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RN7SL201P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL201P expression acts as an unfavorable survival marker, although some lineages such as ESCA and STAD show a favorable association.

LUAD, OV, and ESCA are the cancer types where RN7SL201P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.294	0.690	<.001	90	view →
OV	OS	Tertile	All	0.524	0.846	.001	84	view →
ESCA	DFS	Tertile	IV	0.826	0.284	.034	42	view →
LIHC	OS	Tertile	All	0.403	0.790	.001	36	view →
STAD	DFS	Tertile	III,IV	0.877	0.308	.025	27	view →
SKCM	OS	Tertile	III,IV	0.290	0.729	.005	18	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RN7SL201P–LUAD (OS)

Open the LUAD breakdown →